These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya. Feikin DR; Jagero G; Aura B; Bigogo GM; Oundo J; Beall BW; Karani A; Morpeth S; Njenga MK; Breiman RF BMC Infect Dis; 2010 Jun; 10():186. PubMed ID: 20573224 [TBL] [Abstract][Full Text] [Related]
5. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. Jones N; Huebner R; Khoosal M; Crewe-Brown H; Klugman K AIDS; 1998 Nov; 12(16):2177-84. PubMed ID: 9833859 [TBL] [Abstract][Full Text] [Related]
6. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review. Singh J; Sundaresan S; Manoharan A; Shet A Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387 [TBL] [Abstract][Full Text] [Related]
7. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605 [TBL] [Abstract][Full Text] [Related]
8. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program. Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392 [TBL] [Abstract][Full Text] [Related]
9. Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009. Srifeungfung S; Tribuddharat C; Comerungsee S; Chatsuwan T; Treerauthanaweeraphong V; Rungnobhakhun P; Nunthapisud P; Chokephaibulkit K Vaccine; 2010 Apr; 28(19):3440-4. PubMed ID: 20199759 [TBL] [Abstract][Full Text] [Related]
10. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon. Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G; Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352 [TBL] [Abstract][Full Text] [Related]
11. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Shibl AM; Memish ZA; Al-Kattan KM Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355 [TBL] [Abstract][Full Text] [Related]
13. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. Plouffe JF; Breiman RF; Facklam RR JAMA; 1996 Jan; 275(3):194-8. PubMed ID: 8604171 [TBL] [Abstract][Full Text] [Related]
14. The prevalence and antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients at Jikei University Hospitals after the implementation of the pneumococcal vaccination program in Japan. Ando T; Masaki T; Kono M; Nagano Y; Sakamoto K; Tamura T; Abe M; Matsushima M; Nakada K; Matsuura T J Infect Chemother; 2020 Jul; 26(7):769-774. PubMed ID: 32417263 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic use in Thailand: quantifying impact on blood culture yield and estimates of pneumococcal bacteremia incidence. Rhodes J; Hyder JA; Peruski LF; Fisher C; Jorakate P; Kaewpan A; Dejsirilert S; Thamthitiwat S; Olsen SJ; Dowell SF; Chantra S; Tanwisaid K; Maloney SA; Baggett HC Am J Trop Med Hyg; 2010 Aug; 83(2):301-6. PubMed ID: 20682872 [TBL] [Abstract][Full Text] [Related]
18. Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae isolates in patients aged 50 years or older in Thailand. Srifeungfung S; Phongsamart W; Tribuddharat C; Chatsuwan T; Rungnobhakhun P; Sapcharoen S; Chokephaibulkit K Hum Vaccin Immunother; 2014; 10(1):40-4. PubMed ID: 24030588 [TBL] [Abstract][Full Text] [Related]
19. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study. Charfi F; Smaoui H; Kechrid A Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353 [TBL] [Abstract][Full Text] [Related]
20. Changes in the incidence of Streptococcus pneumoniae bacteremia and its serotypes over 10 years in one hospital in South Korea. Park M; Kim HS; Shin KS; Kim HS; Park JY; Song W; Cho HC; Lee KM; Kim JS Vaccine; 2014 Nov; 32(48):6403-7. PubMed ID: 25305566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]